Video

Alan Kaye, MD, PhD: Treating Pain During COVID-19

Leveraging telemedicine during COVID-19.

Treating pain during the coronavirus disease 2019 (COVID-19) pandemic has been difficult.

Unless there was an unusual emergency, interventional pain procedures were considered elective, Alan Kaye, MD, PhD, of LSU Health School of Medicine, told HCPLive® in a recent interview. Most were canceled because of concerns about supplies and the doctors did not want patients to get exposed.

“Pain medicine has gone through radical changes with telemedicine becoming the norm,” Kaye said.

The pandemic has been a serious challenge, he added.

Research has been published touching on all of the issues related to treating pain during COVID-19.

While pain doctors and rheumatologists alike have needed to shift its focus and use telemedicine to treat patients, some rheumatologists may have already been leveraging the technology for consults with patients.

“Every doctor and every person in America and probably worldwide have been affected by COVID,” Kaye said. He added it should not be surprising the Congress of Clinical Rheumatology East 2020 meeting was taking place virtually over laptops.

Hear more from Kaye in the video interview clip posted above.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.